India’s Orchid Pharma is in advanced negotiations to out-license its breakthrough antibiotic enmetazobactam in the USA, a move that could mark the company’s commercial entry into the world’s largest ...

AlzeCure Pharma has signed an out-licensing and collaboration agreement with Denmark’s privately held QuantumCell, granting ...

India’s pharmaceutical industry is witnessing a surge in global partnerships, with countries such as Switzerland, Uzbekistan, ...

Danish drugmaker Novo Nordisk has won conditional UK marketing authorization for Wegovy (semaglutide) in adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-advanced ...

Russian pharmaceutical companies and global drugmakers operating in the local market have called on the national government to speed the process of entering new drugs in public procurements after ...

US oncology biotech Revolution Medicines has reported early Phase I/II data for zoldonrasib-based combinations in RAS G12D-mutant metastatic pancreatic ductal adenocarcinoma (PDAC), supporting two ...

US drugmaker United Therapeutics yesterday revealed that it has acquired Thymmune Therapeutics, a privately held, pre-clinical stage biotechnology company.

Indian contract research, development and manufacturing organization Syngene International has appointed Siddharth Mittal as managing director and chief executive.

Danish biotech company Muna Therapeutics has named Michel Detheux as chief executive as it prepares to move its lead ...

M&A was again a big feature in last week's news, with AbbVie’s acquisition of Apogee Therapeutics, along with its atopic ...

Scribe Therapeutics, a Phase I biotech developing CRISPR therapies for cardiovascular diseases, filed on Thursday with the Securities & Exchange Commission (SEC) to raise up to $75 million in an ...

As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on patient-reported outcomes to carve out space for Briumvi ...